FISHERS, IND. (January 9, 2024) – BiomEdit CEO Aaron Schacht was recently named 2023 Visionary CEO in the S&P Global Animal Health Awards for his role in leading the emerging animal health biotechnology company and influence as an industry key opinion leader. The annual awards from S&P Global celebrate innovation and leadership within the animal health sector. It is the second award in as many years for BiomEdit, which earned Best Start-Up in 2022.
The judging panel, composed of eight global experts, provided the following perspective on Schacht in the December 21, 2023, announcement: He has a clear vision for BiomEdit to discover and develop animal health products that leverage microbiome science and synthetic biology. Mr. Schacht has built a diverse team, established mutually beneficial partnerships with industry leaders and peers, and committed to innovation in just the company’s second year. He previously helped BiomEdit secure $36.5 million – one of the animal health industry’s largest-ever series A rounds.
In less than two years since the company was established, BiomEdit’s accomplishments have included:
- Establishing a ground-breaking, long-term strategic research and commercial partnership with Nutreco to bring livestock producers innovative feed additives
- Advancing first-of-its-kind non-antibiotic engineered bacteria targeting necrotic enteritis into pivotal stage development and establishing a regulatory pathway with USDA
- Partnering with the Indiana Biosciences Research Institute to form an Integrated Drug Discovery Collaboration
- Announcing a first-of-its-kind collaboration with Athian, the world’s first cloud-based carbon marketplace for the livestock industry
- Earning a $4.5M grant from the Bill and Melinda Gates Foundation to accelerate research and development of methane-reducing solutions
“I’m humbled and honored to be recognized as the 2023 Visionary CEO, as this is truly a reflection of the accomplishments of the strong and passionate team, board of directors and investors we have at BiomEdit,” said Aaron Schacht, CEO of BiomEdit. “This is such an exciting time as we witness a scientific revolution, where microbiome science, synthetic biology and animal health converge.”
